Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Guinness says

Incyte, a pharmaceutical company, is a discount stock trading in the $5 range. The firm is developing drugs to battle cancer that could help it achieve a turnaround.

Incyte showed promise in early 2000 and its stock price shot up to $144.53 at one point. But it fell when other companies developing products based on the human genome dropped.

Incyte's price could triple in coming months if it achieves its goals, Guinness said. Shares of Incyte closed down 11 cents at $5.30 on Wednesday.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.